Hardy WD - Search Results

1

The effect of zidovudine treatment on serum neopterin and beta 2-microglobulin levels in mildly symptomatic, HIV type 1 seropositive individuals.

Bass HZ, Hardy WD, Mitsuyasu RT, Taylor JM, Wang YX, Fischl MA, Spector SA, Richman DD, Fahey JL. Bass HZ, et al. Among authors: hardy wd. J Acquir Immune Defic Syndr (1988). 1992;5(3):215-21. J Acquir Immune Defic Syndr (1988). 1992. PMID: 1346807 Clinical Trial.

2

Immune changes in HIV-1 infection: significant correlations and differences in serum markers and lymphoid phenotypic antigens.

Bass HZ, Nishanian P, Hardy WD, Mitsuyasu RT, Esmail E, Cumberland W, Fahey JL. Bass HZ, et al. Among authors: hardy wd. Clin Immunol Immunopathol. 1992 Jul;64(1):63-70. doi: 10.1016/0090-1229(92)90060-2. Clin Immunol Immunopathol. 1992. PMID: 1376654

3

Eleven lymphoid phenotypic markers in HIV infection: selective changes induced by zidovudine treatment.

Bass HZ, Hardy WD, Mitsuyasu RT, Wang YX, Cumberland W, Fahey JL. Bass HZ, et al. Among authors: hardy wd. J Acquir Immune Defic Syndr (1988). 1992;5(9):890-7. J Acquir Immune Defic Syndr (1988). 1992. PMID: 1512689 Clinical Trial.

4

A health status questionnaire using 30 items from the Medical Outcomes Study. Preliminary validation in persons with early HIV infection.

Wu AW, Rubin HR, Mathews WC, Ware JE Jr, Brysk LT, Hardy WD, Bozzette SA, Spector SA, Richman DD. Wu AW, et al. Among authors: hardy wd. Med Care. 1991 Aug;29(8):786-98. doi: 10.1097/00005650-199108000-00011. Med Care. 1991. PMID: 1875745

5

The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group.

Fischl MA, Richman DD, Hansen N, Collier AC, Carey JT, Para MF, Hardy WD, Dolin R, Powderly WG, Allan JD, et al. Fischl MA, et al. Among authors: hardy wd. Ann Intern Med. 1990 May 15;112(10):727-37. doi: 10.7326/0003-4819-112-10-727. Ann Intern Med. 1990. PMID: 1970466 Clinical Trial.

6

Functional status and well-being in a placebo-controlled trial of zidovudine in early symptomatic HIV infection.

Wu AW, Rubin HR, Mathews WC, Brysk LM, Bozzette SA, Hardy WD, Atkinson JH, Grant I, Spector SA, McCutchan JA, et al. Wu AW, et al. Among authors: hardy wd. J Acquir Immune Defic Syndr (1988). 1993 May;6(5):452-8. J Acquir Immune Defic Syndr (1988). 1993. PMID: 8483109 Clinical Trial.

7

Safety and efficacy of the peptide-based therapeutic vaccine for HIV-1, Vacc-4x: a phase 2 randomised, double-blind, placebo-controlled trial.

Pollard RB, Rockstroh JK, Pantaleo G, Asmuth DM, Peters B, Lazzarin A, Garcia F, Ellefsen K, Podzamczer D, van Lunzen J, Arastéh K, Schürmann D, Clotet B, Hardy WD, Mitsuyasu R, Moyle G, Plettenberg A, Fisher M, Fätkenheuer G, Fischl M, Taiwo B, Baksaas I, Jolliffe D, Persson S, Jelmert O, Hovden AO, Sommerfelt MA, Wendel-Hansen V, Sørensen B. Pollard RB, et al. Among authors: hardy wd. Lancet Infect Dis. 2014 Apr;14(4):291-300. doi: 10.1016/S1473-3099(13)70343-8. Epub 2014 Feb 11. Lancet Infect Dis. 2014. PMID: 24525316 Clinical Trial.

8

Zidovudine compared with didanosine in patients with advanced HIV type 1 infection and little or no previous experience with zidovudine. AIDS Clinical Trials Group.

Dolin R, Amato DA, Fischl MA, Pettinelli C, Beltangady M, Liou SH, Brown MJ, Cross AP, Hirsch MS, Hardy WD, et al. Dolin R, et al. Among authors: hardy wd. Arch Intern Med. 1995 May 8;155(9):961-74. Arch Intern Med. 1995. PMID: 7726705 Clinical Trial.

9

Zidovudine (AZT) monotherapy selects for the A360V mutation in the connection domain of HIV-1 reverse transcriptase.

Brehm JH, Scott Y, Koontz DL, Perry S, Hammer S, Katzenstein D, Mellors JW, Sluis-Cremer N; AIDS Clinical Trials Group Study 175 Protocol Team. Brehm JH, et al. PLoS One. 2012;7(2):e31558. doi: 10.1371/journal.pone.0031558. Epub 2012 Feb 21. PLoS One. 2012. PMID: 22363673 Free PMC article. Clinical Trial.

10

Combined ganciclovir and recombinant human granulocyte-macrophage colony-stimulating factor in the treatment of cytomegalovirus retinitis in AIDS patients.

Hardy WD. Hardy WD. J Acquir Immune Defic Syndr (1988). 1991;4 Suppl 1:S22-8. J Acquir Immune Defic Syndr (1988). 1991. PMID: 1848618 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

210 results

Search Page

Filters